13.53 USD
▼-0.01-0.07%
盘后 13.59 0.00%
2026-11-20
市值
$194.20M
市盈率
—
EPS
-2.63
股息率
—
52 周区间
11.80 – 19.70
成交量
60.12K
Beta
0.04
目标价
29.67
52W 低 11.8052W 高 19.70
价格走势
公司简介
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other ...